青光眼门诊患者自行使用毛果芸香碱进行自我药疗。
Self-medication with pilocarpine among outpatients in a glaucoma clinic.
作者信息
Norell S E, Granström P A
出版信息
Br J Ophthalmol. 1980 Feb;64(2):137-41. doi: 10.1136/bjo.64.2.137.
Abstract
A recording medication monitor and fluorescein technique were used to study self-medication by 82 patients with primary open-angle glaucoma for whom pilocarpine eye drops 3 times a day had been prescribed. Of these patients 34 (41%) missed 6 or more doses during a 20-day period, and for 35 (43%) an 8-hour dose interval was exceeded at least 20% of the time. Consequences may include lack of effectiveness in preventing visual loss and unnecessary prescription of more potent, and more toxic, drugs.
摘要
使用记录式药物监测器和荧光素技术，对82例原发性开角型青光眼患者的自我用药情况进行了研究，这些患者被处方每日3次使用毛果芸香碱滴眼液。在这82例患者中，34例（41%）在20天内漏服了6剂或更多剂量，35例（43%）有至少20%的时间超过了8小时的给药间隔。后果可能包括在预防视力丧失方面缺乏效果，以及不必要地开具更强效、毒性更大的药物。
相似文献
1
Self-medication with pilocarpine among outpatients in a glaucoma clinic.青光眼门诊患者自行使用毛果芸香碱进行自我药疗。
Br J Ophthalmol. 1980 Feb;64(2):137-41. doi: 10.1136/bjo.64.2.137.
2
A medication monitor and fluorescein technique designed to study medication behaviour.一种用于研究药物行为的药物监测器和荧光素技术。
Acta Ophthalmol (Copenh). 1980 Jun;58(3):459-67. doi: 10.1111/j.1755-3768.1980.tb05747.x.
3
Monitoring compliance with pilocarpine therapy.
Am J Ophthalmol. 1981 Nov;92(5):727-31. doi: 10.1016/s0002-9394(14)74670-7.
4
Medication behaviour. A study of outpatients treated with pilocarpine eye drops for primary open-angle glaucoma.用药行为。一项关于使用毛果芸香碱滴眼液治疗原发性开角型青光眼门诊患者的研究。
Acta Ophthalmol Suppl. 1980(143):1-28.
5
Improving medication compliance: a randomised clinical trial.提高药物治疗依从性：一项随机临床试验。
Br Med J. 1979 Oct 27;2(6197):1031-3. doi: 10.1136/bmj.2.6197.1031.
6
Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.未遵医嘱进行药物治疗的青光眼患者：临床及行为学方面
Br J Ophthalmol. 1982 Jul;66(7):464-70. doi: 10.1136/bjo.66.7.464.
7
Compliance with topical pilocarpine treatment.局部毛果芸香碱治疗的依从性。
Am J Ophthalmol. 1986 May 15;101(5):515-23. doi: 10.1016/0002-9394(86)90939-6.
8
Pilocarpine medication in open-angle glaucoma. A study using pilocarpine eyedrops and an ocular therapeutic system.
Acta Ophthalmol (Copenh). 1979 Feb;57(1):55-62. doi: 10.1111/j.1755-3768.1979.tb06659.x.
9
[Pilocarpine-ocusert-p-40 in the handicapped glaucoma patient (author's transl)].匹鲁卡品眼用控释膜P-40在青光眼残疾患者中的应用（作者译）
Klin Monbl Augenheilkd. 1975 Jul;167(1):55-61.
10
Piloplex, a new long-acting pilocarpine polymer salt. A: Long-term study.匹鲁卡品聚合物，一种新型长效匹鲁卡品聚合物盐。A：长期研究。
Br J Ophthalmol. 1979 Jan;63(1):45-7. doi: 10.1136/bjo.63.1.45.
引用本文的文献
1
Ophthalmic Nanoemulsions: From Composition to Technological Processes and Quality Control.眼科纳米乳剂：从组成到技术工艺和质量控制。
Mol Pharm. 2021 Oct 4;18(10):3719-3740. doi: 10.1021/acs.molpharmaceut.1c00650. Epub 2021 Sep 17.
2
Individual factors increasing complexity of drug treatment-a narrative review.个体因素增加药物治疗的复杂性——叙述性综述。
Eur J Clin Pharmacol. 2020 Jun;76(6):745-754. doi: 10.1007/s00228-019-02818-7. Epub 2020 Apr 1.
3
Promising Approach in the Treatment of Glaucoma Using Nanotechnology and Nanomedicine-Based Systems.利用纳米技术和基于纳米医学的系统治疗青光眼的有前途的方法。
Molecules. 2019 Oct 22;24(20):3805. doi: 10.3390/molecules24203805.
4
Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review.青光眼和高眼压症患者治疗依从性和持续性的客观评估：一项系统评价
Patient Prefer Adherence. 2011;5:441-63. doi: 10.2147/PPA.S23780. Epub 2011 Sep 23.
5
The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.青光眼药物治疗依从性、滴眼技术与视野缺损严重程度之间的关系。
Ophthalmology. 2011 Dec;118(12):2398-402. doi: 10.1016/j.ophtha.2011.05.013.
6
First-year treatment costs among new initiators of topical prostaglandin analogs: pooled results.局部用前列腺素类似物新使用者的第一年治疗费用：汇总结果。
Clin Ophthalmol. 2010 May 14;4:437-45. doi: 10.2147/opth.s10486.
7
First-year treatment costs among new initiators of topical prostaglandin analogs.
Clin Ophthalmol. 2009;3:637-44. doi: 10.2147/opth.s7113. Epub 2009 Nov 16.
8
Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.未遵医嘱进行药物治疗的青光眼患者：临床及行为学方面
Br J Ophthalmol. 1982 Jul;66(7):464-70. doi: 10.1136/bjo.66.7.464.
9
A dose-response study of oral atenolol administered once daily in patients with raised intra-ocular pressure.
Graefes Arch Clin Exp Ophthalmol. 1982;218(2):96-8. doi: 10.1007/BF02153719.
10
Compliance with treatment of patients with chronic open-angle glaucoma.慢性开角型青光眼患者的治疗依从性。
Br J Ophthalmol. 1983 Jan;67(1):46-9. doi: 10.1136/bjo.67.1.46.
本文引用的文献
1
Failure of children to receive penicillin by mouth.儿童未能口服青霉素。
N Engl J Med. 1963 Jun 13;268:1334-8. doi: 10.1056/NEJM196306132682404.
2
Outpatient P.A.S. therapy.门诊P.A.S. 疗法
Lancet. 1957 Nov 2;273(7001):871-2. doi: 10.1016/s0140-6736(57)90006-5.
3
Evaluation of recall system for glaucoma suspects and patients.青光眼疑似患者和患者召回系统的评估
Sight Sav Rev. 1967 Summer;37(2):78-82.
4
Doctor-patient relationship in glaucoma therapy.
Arch Ophthalmol. 1966 Feb;75(2):204-6. doi: 10.1001/archopht.1966.00970050206011.
5
The inaccuracy in using interviews to estimate patient reliability in taking medications at home.采用访谈法评估患者在家服药可靠性时存在的不准确性。
Med Care. 1969 Jan-Feb;7(1):49-54. doi: 10.1097/00005650-196901000-00006.
6
Visual loss in a glaucoma clinic. I. Sociological considerations.
Invest Ophthalmol. 1970 Jan;9(1):73-82.
7
Pilocarpine and intraocular pressure. Duration of effectiveness of 4 percent and 8 percent pilocarpine instillation.
Arch Ophthalmol. 1974 Feb;91(2):104-6. doi: 10.1001/archopht.1974.03900060110004.
8
Patients' viewpoint of glaucoma therapy.患者对青光眼治疗的观点。
Sight Sav Rev. 1972 Winter;42(4):213-21.
9
Medication monitor for ophthalmology.眼科用药监测仪
Am J Ophthalmol. 1974 Nov;78(5):774-8. doi: 10.1016/0002-9394(74)90299-2.
10
A comparison of patient compliance in treated vs untreated ocular hypertension.治疗性与未治疗性高眼压症患者依从性的比较。
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976 Mar-Apr;81(2):277-85.
Zotero 插件